Baskaran Rengarajan, Shanmugam Srinivasan, Nagayya-Sriraman Santhoshkumar, Kim Ju Hyun, Jeong Tae Chun, Yong Chul Soon, Choi Han-Gon, Yoo Bong Kyu
College of Pharmacy, Yeungnam University, Kyungbuk, Korea.
Arch Pharm Res. 2008 Jul;31(7):938-44. doi: 10.1007/s12272-001-1250-1. Epub 2008 Aug 14.
Interaction of a drug with other drugs and dietary supplements is becoming an emerging issue for patients and health insurance authorities due to awareness of adverse drug event. In this study, we examined the effects of coenzyme Q10 (CoQ10), one of the most popular dietary supplements, on the pharmacokinetic parameters of theophylline in rats. The pharmacokinetic parameters of theophylline changed significantly when the drug was administered after five consecutive days of pretreatment with CoQ10. Time to reach maximum plasma concentration of theophylline delayed when the drug was administered after the pretreatment with CoQ10. Maximum plasma concentration and area under the curve of theophylline were about two-fold increased and other pharmacokinetic parameters such as half-life and volume of distribution were also changed significantly. Therefore, although CoQ10 is generally considered a safe dietary supplement, it appears that patients on theophylline therapy should use caution when they take CoQ10.
由于对药物不良事件的认识,药物与其他药物及膳食补充剂之间的相互作用正成为患者和健康保险机构日益关注的问题。在本研究中,我们检测了最受欢迎的膳食补充剂之一辅酶Q10(CoQ10)对大鼠体内茶碱药代动力学参数的影响。在连续五天用CoQ10预处理后给予茶碱,其药代动力学参数发生了显著变化。在用CoQ10预处理后给予茶碱时,达到茶碱最大血浆浓度的时间延迟。茶碱的最大血浆浓度和曲线下面积增加了约两倍,其他药代动力学参数如半衰期和分布容积也发生了显著变化。因此,尽管CoQ10通常被认为是一种安全的膳食补充剂,但接受茶碱治疗的患者在服用CoQ10时似乎应谨慎。